header logo image


Page 851«..1020..850851852853..860870..»

Bengaluru: Revellers lose sight of safety and also their eyesight on Deepavali – The New Indian Express

November 4th, 2019 11:45 am

By Express News Service

BENGALURU: The city saw at least 40 cases of firecracker-related injuries in just the first two days. Unfortunately, the number of cases did not come down even on the last day of Deepavali.

Sankara Eye Hospital in the city received 16 cases of eye injuries on Tuesday, of which eight of the patients were children. Minto Eye Hospital received six cases of eye injuries caused by firecrackers and unfortunately, two of these patients lost their vision in one eye.

Pavan (22), a resident of Chikagolaratti, was a patient. He had placed a Lakshmi bomb in a paint box to increase the noise level. When the bomb burst, the lid of the paint box flew in the air and hit his right eye. Pavan has now lost sight in his right eye.

The impact of the hot paint lid hitting him and the chemicals in the crackers impacted his eye and he has lost his vision in the right eye. We did a surgery in order to retain the globe but now he has lost his eye permanently and in the left eye he had multiple corneal foreign objects, which were cleared, said Dr Sujatha Rathod, Director of Minto Eye Hospital.

In a similar incident, 13-year-old Rohan tried bursting a bomb inside a pipe in order to make it even louder. But due to the impact of the cracker, the pipe flew in the air and hit Rohans right eye.

Rohan was unable to perceive light and it is clear that he has lost his vision in the right eye. His is also a global rupture, Rathod added.

Narayana Nethralaya, Super Speciality Eye Care Hospital, had 10 cases on Monday. They were all minor cases with most of them coming with red-eye and they were cured immediately, a spokesperson from Narayana Nethralaya said.

Manipal Hospital received patients who suffered from hearing issues. We received two cases of adults who suffered persistent ringing in the ears, called tinnitus, and minimal hearing loss owing to noise levels crossing 125 decibels. This could turn into a life long malady if left untreated. If not, it is either self-resolving or can be rectified with medication, said Dr Vijay Rangachari, consultant ENT surgeon, Manipal Hospitals, Whitefield.

Cleaning up: BBMP draws rangolis, educates citizens

A day after the Deepavali revelry, many streets were strewn with cardboard boxes, paper, burnt sparklers and firecrackers, to say the least. On Sunday and Monday, pourakarmikas gathered all such waste from all the 198 wards and assembled the garbage in all the wards.

On Tuesday, the waste was kept in one spot to show the citizens what they have left behind. The message we wanted to give is that this too is their waste and they must take responsibility to clean it up. We got them to join us in sweeping the waste, said Sandhya, medical health officer, BBMP. Colourful rangolis were drawn at the spots where the black spots were.

View original post here:
Bengaluru: Revellers lose sight of safety and also their eyesight on Deepavali - The New Indian Express

Read More...

Allergan drives home the seriousness of glaucoma with latest awareness campaign – FiercePharma

November 4th, 2019 11:45 am

Glaucoma is often underestimated by patients. Allergans new campaign, My Glaucoma, looks to raise awareness of the seriousness of the disease, withreal patient and caregiver perspectives on the difficulties of living with it.

The campaign is informed in part by research that Allergan, which markets the glaucoma-fighting treatments Lumigan and Alphagan, did in conjunction with the Glaucoma Research Foundation.They found that while 3 in 4 patients are concerned they will lose their vision to glaucoma, 40% consider it to be only somewhat serious or not serious at all.

In fact, 27% of patients will go blind in one eye over a 10-year period, according to research published inthe American Journal of Ophthalmology.

Industry Insight Survey: Direct-to-Patient Distribution of Clinical Supplies

What is your perspective on offering a DTP option? Share your thoughts for a chance to win a $5 Amazon gift card.

RELATED: Eye-med maker Allergan takes on preventable blindness with nationwide vision-screening push

As a pharma company in eye care, Allergan feels responsible that there needs to be more awareness around this. We didnt do this in isolation, we partnered with Glaucoma Research Foundation and did a survey of 500 patients with glaucoma that provided challenges and things that impact their lives, Matthew Bolton, Allergan's executive director of glaucoma marketing, said.

But unlike with the company's previous initiatives, this is "one of the first times we've approached glaucoma from a caregiver's lens," he said.

"I think a lot of times people think about glaucoma and the challenges just that that personal patient experiences, but it impacts a lot of people around them," Bolton added.

In online videos, for instance, the husband and son of Patrice, who has lost 60% of her eyesight to glaucoma, talk about her struggle and its effects on them. Her husband Bob talks about having to give up playing tennis in a group of friends.

RELATED: Rapper Common joins Allergan to warn in rhymeand swirling colorabout vision loss

It was kind of new to me in a sense, how does it affect your life. I didnt really realize. It took me a while to catch on as far as some of the things she needed me to do, her husband Bob says. His voice breaks and he sheds tears as he advises people who are having trouble seeing to get checked before it gets worse. Because it will get worse. Thats what happened to my wife. And it was too late. She makes up for it, but she still cant do a lot of stuff," he says.

The website also includes fact sheets and discussion guides. Another feature on the site is a visual that allows visitors to slide a button to see for themselves the loss of vision over time to glaucoma. The campaign launched on World Sight Day in October but will continue to run through the year and beyond,with additions and evolved content, Bolton said.

Read the original post:
Allergan drives home the seriousness of glaucoma with latest awareness campaign - FiercePharma

Read More...

Air force veteran’s fight against blindness from two rare conditions – Eastern Daily Press

November 4th, 2019 11:45 am

PUBLISHED: 14:59 04 November 2019 | UPDATED: 15:28 04 November 2019

Reece Hanson

Nick Barber (right) marching at the Cenotaph. PHOTO: Blind Veterans UK.

Archant

A blind air force veteran who lost his sight through two rare eye conditions has hailed a charity for "changing his life."

Email this article to a friend

To send a link to this page you must be logged in.

Nick Barber joined the Royal Air Force as a police dog handler in 1983, serving in the UK and in Germany at RAF Laarbruch, the training base for dogs.

He also completed a tour in the Falkland Islands where he was responsible for moving the dog handling facility from Stanley to RAF Mount Pleasant.

In 2001, he lost his sight through a combination of Bull's Eye Maculopathy and the genetic condition Retinitis Pigmentosa.

Mr Barber said: "If you imagine a normal sighted person's sight is like a beach ball, mine is like a ping pong ball.

"I've got some sight in the centre of my vision but absolutely no peripheral vision.

"Losing my sight hit me really hard and that first six months was terribly frustrating with not knowing what was causing it and finding out there was no treatment. I had to give up my job and was left feeling very depressed.

After discovering the charity Blind Veterans UK, Mr Barber has rediscovered a love for photography, going on to run courses at the charity's training and rehabilitation centres in Brighton and Llandudno.

He said: "My wife and I went for an induction week at the charity's Brighton Centre, which was very nerve-wracking for both of us beforehand.

"A man called Martin showed us around the whole building and at the end we found out he had no sight at all. This was a kick up the backside for me and from then on I haven't looked back.

"The biggest affect it had was the one-to-one meetings encouraging me to talk about how I felt about blindness which then made it easier to discuss with my wife. That changed both our lives."

On Remembrance Sunday, Mr Barber will march with 100 other blind veterans at the Cenotaph in London.

He said: "Being at the Cenotaph is different to anything else. Even the build-up is electric. You feel hugely proud and the hairs on the back of your neck really do stand up.

"The day is all about remembering all those who have served and fallen in war. My grandad served and was injured in the First World War and I always think of him during the silence."

Continue reading here:
Air force veteran's fight against blindness from two rare conditions - Eastern Daily Press

Read More...

The importance of early detection in macular degeneration – Australian Hospital + Healthcare Bulletin

November 4th, 2019 11:45 am

Age-related macular degeneration (AMD) refers to a group of retinal eye diseases that cause progressive loss of central vision, leaving the peripheral or side vision intact. The condition affects the ability to read, drive, recognise faces and perform activities that require detailed vision.

AMD is the leading cause of legal blindness in Australia, responsible for 50% of all cases of blindness. Vision Australia reports that a person is considered legally blind if they cannot see, at six metres, what someone with normal vision can see at 60 metres or if their field of vision is less than 20 degrees in diameter.

AMD affects one in seven Australians over 50 years and is projected to increase with the nations ageing population.

A recent survey commissioned by the Macular Disease Foundation Australia (MDFA) found that although awareness of AMD is high, one in three Australians have not had their macula checked in the last two years.

In partnership with the MDFA, Novartis has launched the See Whats Next campaign to remind older Australians of the importance of regular eye tests to protect against macular degeneration.

The campaign created a video to simulate what life is like for someone living with AMD.

Detecting the disease early can provide a window of opportunity to avoid or delay the burden of vision loss on both the patient and their families. The earlier that AMD is detected, the earlier steps can be taken to help slow its progression and save sight through treatment and/or lifestyle modifications.

The MDFA advises that an optometrist or ophthalmologist should be sought immediately in the case of any sudden changes to vision.

The early signs of AMD may not always be noticeable, but with wet (neovascular) AMD, the most aggressive form, vision changes are often sudden and severe, said MDFA CEO Dee Hopkins.

At the Macular Disease Foundation Australia, we believe in the value of awareness and early detection. It is important to have your eyes examined and macula checked by an eyecare professional on a regular basis.

AMD often affects the ability to read, drive, recognise faces and perform activities that require detailed vision.

Paul Mitchell, Professor of Ophthalmology at the University of Sydney and Director at the Centre for Vision Research at the Westmead Institute for Medical Research, emphasised the importance of seeking help early.

Wet AMD typically causes rapid and severe vision loss, particularly if untreated.

Current anti-VEGF therapy has now been shown in many countries to be associated with a major reduction in blindness and visual impairment from wet AMD. As overall AMD prevalence and incidence are exponentially age related, the ageing of the Australian population is leading to an increase in presentation of wet AMD cases, he explained.

It is critical for the best outcomes from treatment of wet AMD that patients present as soon as possible after developing worsening vision. Regular eye examinations with sensitive testing of retinal function are critical to achieving early diagnosis of wet AMD; the starting vision is the principal determinant of the final vision after treatment, and wet AMD leads to scarring that leads to permanent vision loss.

The aim should be to see patients within days or a week or two of new symptoms, or signs indicating possible progression to wet AMD, Professor Mitchell said.

Two-thirds of AMD-related blindness is caused by wet (neovascular) AMD, a condition that affects 133,000 Australians. Wet AMD is caused by the formation of fragile blood vessels that leak fluid and blood within and under the retina.

As a chronic, degenerative eye disease, wet AMD often has a rapid and devastating impact on patients lives, causing them to lose their independence and struggle to do the things the things they enjoy, particularly if the disease is not managed early.

Dry (atrophic) AMD iscaused by the gradual lossof retinal cells. It may lead to a gradual loss of central vision. Currently there is no treatment available for the dry form.

Read more here:
The importance of early detection in macular degeneration - Australian Hospital + Healthcare Bulletin

Read More...

Effective Tactics of Gesture Recognition Market Development History Forecast 2028 | Apple Inc, eyeSight Technologies Ltd. – 5Gigs News

November 4th, 2019 11:45 am

New York City, NY: November 04, 2019 Published via (Wired Release) Global Gesture Recognition Market 2019 can be defined as a board in which proficiency test is done to get the statistical surveying Gesture Recognition Market informationwhich will be useful for the new market participants or recognized Gesture Recognition players. Huge informatic data is enclosed in Gesture Recognition market examine through which a record of an advantageous hot spot for investigators, administrators, Gesture Recognition industry specialist and additionally other important individuals prepare to-access alongside Gesture Recognition self-structured examination together side tables and charts which help to derive Gesture Recognition market patterns, drivers and currency or financial battles. As a combination of the Linear Motors data coordination and investigation limits with the findings that are appropriate. Similarly, this report has predicted a strong future rise of this Gesture Recognition market in each geographic and its segments.

The analysis starts up by Gesture Recognition market survey and continues on expanded probabilities of this Gesture Recognition market. By considering all elements examination of this Gesture Recognition market is done from the report. Upstream/downstream, customer analysis, development platform, Gesture Recognition industry change tendency, recommendations, firm outlook, income offer are also included in this Gesture Recognition examination. In this report SWOT analysis of their best players from the Gesture Recognition market are also provided.

Growth Focusing on Major Key Players- Apple Inc, eyeSight Technologies Ltd., Infineon Technologies AG, Cognitec Systems GmbH, GestureTek Inc, PointGrab Ltd., SoftKinetic-Optrima S.A., Cross Match Technologies Inc, Elliptic Laboratories AS, Intel Corporation

For Better Understanding, Go Through Free Sample PDF of The Gesture Recognition Market Report @https://marketresearch.biz/report/gesture-recognition-market/request-sample

Global Gesture Recognition Market: Regional Segment Analysis

North America (USA, Canada, and Mexico)

Europe (Russia, France, Germany, UK, and Italy)

Asia-Pacific (China Korea, India, Japan, and Southeast Asia)

South America (Brazil, Columbia, Argentina, etc)

The Middle East and Africa (Nigeria, UAE, Saudi Arabia, Egypt, and South Africa)

Global Gesture Recognition Market Segmentation Analysis:

Segmentation by technology:

Touch-based Gesture Recognitiono Multi-Touch Systemo Motion GestureTouchless Gesture Recognitiono Capacitive/Electric Fieldo Infrared Arrayo Ultrasonic Technologyo 2D Camera-Based Technologyo 3D Vision TechnologiesSegmentation by end-use industry:

Aerospace & DefenseAutomotiveConsumer ElectronicsHealthcareOther Industries (Educational Hub, Advertisement & Communication, Gaming)

Key Highlights of the Gesture Recognition Market Research Report:

The report summarizes the Gesture Recognition Market by stating basic product definition, number of product applications, product scope, product cost and price, supply and demand ratio, market overview.

Competitive landscape of all leading key players along with their business strategies, approaches, and latest Gesture Recognition market movements.

It elements market feasibility investment, opportunities, the growth factors, restraints, market risks, and Gesture Recognition business driving forces

It performs a comprehensive study of emerging players of Gesture Recognition business along with the existing ones.

It accomplishes primary and secondary research and resources to estimate top products, market size, and industrial partnerships of Gesture Recognition business.

Global Gesture Recognition market report ends by articulating research findings, data sources, results, list of dealers, sales channels, businesses and distributors along with an appendix.

Customize Report And Inquiry For The Gesture Recognition Market Report:https://marketresearch.biz/report/gesture-recognition-market/#inquiry

The researchers have provided quantitative and qualitative analysis along with absolute opportunity assessment in the report. Also, the report offers Porters Five Forces analysis and PESTLE analysis for more detailed contrast studies. Each section of the report has something valuable to offer to companies for improving their sales and marketing strategy, gross margin, and profit margins. Using the report as a tool for gaining insightful Gesture Recognition market analysis, players can identify the much-required changes in their operation and improve their approach to doing business. Moreover, they will be able to give a tough competition to other players of the global Gesture Recognition market while identifying key growth pockets.

The report provides all-inclusive information to identify market segments that help to improve the quality of business decision-making based on demand, sales, and production based on application-level analysis and regional level. Gesture Recognition report provides data analyzed graphically for a better explanation. Our experts have crafted the detailed study of Gesture Recognition market 2019 in a structured format for better interpretation.

Chapters Covered In Global Gesture Recognition Industry 2019 :

Chapter 1: Definition, Specifications, Classification, Introduction and Scope the Gesture Recognition market 2019

Chapter 2: Exclusive Summery like Manufacturer cost structure, Industry chain structure, suppliers, etc

Chapter 3: Drivers, Displays Trends, and Challenges of the Gesture Recognition market

Chapter 4: By the study of SWOT analysis its investment analysis, displays sales analysis, market analysis, etc

Chapter 5: It evaluates the market by share, segments, by countries, and by manufacturers with revenue and sales by key countries in these various regions.

Chapter 6: Evaluate the leading key vendors of the Global Gesture Recognition market which consists of its Competitive Landscape.

Chapter 7: Gesture Recognition Research Findings and Conclusion, Appendix, system and information source

Browse Complete Report with TOC @https://marketresearch.biz/report/gesture-recognition-market/#toc

About Us:

MarketResearch.biz always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, MarketResearch.biz consulting group has accumulated creative design methods on many high-quality markets investigation and research teams with rich experience. Today, MarketResearch.biz has become a brand of quality assurance in the consulting industry.

This content has been distributed viaWired Releasepress release distribution service. For press release service inquiry, please reach us at[emailprotected].

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue,

Suite 300 New York City, NY 10170,

United States

Tel:+ 1-347-826-1876

Website:https://marketresearch.biz/

Read the original post:
Effective Tactics of Gesture Recognition Market Development History Forecast 2028 | Apple Inc, eyeSight Technologies Ltd. - 5Gigs News

Read More...

BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic…

November 4th, 2019 11:44 am

Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and womens health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, UT from November 5-8. Multiple poster presentations will demonstrate the companys commitment to advancing the research of rare genetic disorders and hereditary conditions, and supporting the genetic counseling community.

Each year NSGC offers a distinct opportunity for genetic counselors and other professionals to learn about the many advancements and extensive research completed within the genetics community, said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. This year, we are proud to add to that body of research with multiple papers, including two that were nominated for best paper, as well as contribute to the networking opportunities throughout the show.

A key focus at GeneDxs booth (#501) is to educate providers about how the laboratory is working to expand genetic testing answers with RNA Studies on select exome and genome results. The adjacent GenPath booth (#611) will highlight the companys full service capabilities as a womens health specialty lab, from preconception through delivery, with a focus on genetic test offerings.

The full set of research to be presented throughout the show includes:

How to Avoid Legal and Ethical Pitfalls as a Genetic Counselor

The Frequency of Cancer-Related Secondary Findings in a Cohort of Individuals Undergoing Clinical Exome Sequencing

Outcomes of Panel Testing in the Context of a Known Familial Variant

Presentation and Germline Status of Individuals Referred for Multigene Hereditary Myelodysplastic Syndrome and Leukemia Testing

Utility and Diagnostic Rates of Exome Sequencing for Ataxia-Related Disorders

Relationship Between Phenotypic Complexity and Diagnostic Results from a Large Autism/Intellectual Disability Panel

Trio-based Genetic Testing for Leukodystrophies: High Positive Diagnostic Rate in Both Adults and Children

Lack of Genotype-Phenotype Correlation in Individuals with DMPK CTG Repeat Expansions

Short-term, Defined Mentorship Program Between Genetic Counselors and Genetic Counseling Assistants

For more information about these sessions, please visit https://www.nsgc.org/conference.

About GeneDx, Inc.

GeneDx, Inc. is a global leader in genomics, providing testing to patients and their families from more than 55 countries. Led by its world-renowned whole exome sequencing program, GeneDx has an acknowledged expertise in rare and ultra-rare genetic disorders, as well as one of the broadest menus of sequencing services available among commercial laboratories. GeneDx offers a suite of additional genetic testing services, including diagnostic testing for hereditary cancers, cardiac, mitochondrial, neurological disorders, prenatal diagnostics and targeted variant testing. GeneDx is a subsidiary of BioReference Laboratories, Inc., a wholly owned subsidiary of OPKO Health, Inc. To learn more, please visit http://www.genedx.com.

About BioReference Laboratories, Inc.

BioReference provides comprehensive testing to physicians, clinics, hospitals, employers, government units, correctional institutions and medical groups. The company is in network with the five largest health plans in the United States, operates a network of 10 laboratory locations, and is backed by a medical staff of more than 160 MD, PhD and other professional level clinicians and scientists. With a leading position in the areas of genetics, womens health, maternal fetal medicine, oncology and urology, BioReference and its specialty laboratories, GenPath and GeneDx, are advancing the course of modern medicine. For more information, visithttps://www.bioreference.com.

About OPKO Health, Inc.

OPKO Health is a diversified healthcare company. In diagnostics, its BioReference Laboratories is one of the nation's largest full service laboratories; GeneDx is a rapidly growing genetic testing business; the 4Kscore prostate cancer test is used to confirm an elevated PSA to help decide about next steps such as prostate biopsy; Claros 1 is a point-of-care diagnostics platform with a total PSA test approved by the FDA. In our pharmaceutical pipeline, RAYALDEE is our first pharmaceutical product to be marketed. OPK88003, a once-weekly oxyntomodulin for type 2 diabetes and obesity recently reported positive data from a Phase 2 clinical trial. Its among a new class of GLP-1/glucagon receptor dual agonists. OPK88004, a SARM (selective androgen receptor modulator) is currently being studied for various potential indications. The companys most advanced product utilizing its CTP technology, a once-weekly human growth hormone for injection, successfully met its primary endpoint and key secondary endpoints in a Phase 3 study and is partnered with Pfizer. OPKO also has research, development, production and distribution facilities abroad. More information is available at http://www.opko.com

Cautionary Statement Regarding Forward-Looking Statements

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding advancing the research of rare genetic disorders and hereditary conditions, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in the OPKO Health, Inc. Annual Reports on Form 10-K filed and to be filed with the Securities and Exchange Commission and in its other filings with the Securities and Exchange Commission. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

See the article here:
BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic...

Read More...

Stem cell therapy approved for MS patients in Scotland – HeraldScotland

November 4th, 2019 11:42 am

MULTIPLE sclerosis campaigners have hailed a huge step forward for patients in Scotland after a stem cell therapy was recommended for use on the NHS for the first time.

Haematopoietic stem cell transplantation (HSCT) has been described as a game-changer for MS after an international clinical trial showed that it could reboot patients immune systems and halt the progress of the disease.

Some patients who had been in wheelchairs prior to treatment said their condition improved so dramatically it was like they had never been diagnosed with MS.

READ MORE: Scots MS patients 'missing out' on pioneering stem cell treatment available in England

The Scottish Health Technologies Group (SHTG) said there is now sufficient evidence for it to recommend making HSCT available on the NHS in Scotland to MS patients who have the relapsing-remitting form of the disease, and who were not responding to drug treatments.

Iain Robertson, chairman of the SHTG, said: Our committee members were able to advise that this treatment should be considered for those with this particular type of MS who have not responded to treatment with disease-modifying therapies.

We hope that our advice will be of use in helping decide the best course of treatment for these patients.

The SHTG also stressed that patients must be made aware of the demands, risks and uncertainties of the treatment, which uses chemotherapy to wipe out patients' 'faulty' immune systems before replenishing it with a transplant of stem cells harvested from their own bone marrow.

It puts patients at high risk from infections, which can be fatal, but the theory is that the treatment works by enabling patients to 'reset' their immune system to stop it attacking the central nervous system as is the case in MS.

READ MORE: Anger of Scots MS patients travelling abroad for stem cell therapy available to some on NHS England

HSCT is not considered an effective treatment for patients with the progressive form of MS, however, as stem cells cannot regrow nerves or repair damaged myelin - the protective sheath which coats nerves.

It will also be unavailable to patients with relapsing-remitting MS who no longer show signs of inflammation on an MRI brain scan.

Scotland has one of the highest rates of MS in the world, but until now Scottish patients seeking HSCT have had to travel overseas to Mexico, Russia and Israel and bankroll their own private treatment at a cost of around 40-60,000.

It has also been available privately in London since 2017, but with a 100,000 price tag.

A small number of MS patients in England have been able to access the treatment on the NHS, however, because there are clinical trials into HSCT taking place at NHS hospitals in Sheffield and London.

Morna Simpkins, director of MS Society Scotland, said: The decision from SHTG to approve HSCT for the treatment of MS is good news and could help in the development of a clear pathway, for people who could potentially benefit, to access it.

We will push to ensure that this decision leads to real change for people with MS by continuing to engage with other groups to offer the treatments, including HSCT, which are right for them.

READ MORE: Stem cells help mother with MS make 'remarkable' recovery

The SHTG said eligible patients must have equal access to the procedures regardless of where they live, but it is unlikely all health boards will be able to provide it.

The MS Society wants a centre, or centres, of excellence set up where patients from across Scotland can be referred.

Lucy Clarke from the Scottish HSCT Network said the recommendation was "a huge step forward" for people in Scotland living with MS.

Ms Clarke underwent HSCT in Russia and credits it with substantially reversing her disability.

She added: This important decision supports HSCT as a treatment option where other treatments have failed. We will continue to push so that this treatment is available to people in Scotland who need it.

A Scottish Government spokeswoman said: We are grateful to the Scottish Health Technologies Group for this important work.

"NHS Boards are expected to consider their advice on technologies in the planning and provision of its services and clinicians are expected to follow their professional judgement, working within the management structure of their Board.

We will work closely with MS Society Scotland, other third sector bodies and the clinical community to consider what the Technologies Groups findings means for provision in Scotland, including the information that needs to be available to people about eligibility and risks.

More:
Stem cell therapy approved for MS patients in Scotland - HeraldScotland

Read More...

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 to 2024 Structure with Top down & Bottom up Approach, Technological Trends…

November 4th, 2019 11:42 am

The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report offers a sorted out perspective by the simplified information connected to Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market gives a wide stage offering numerous open doors for different businesses, firms, associations, and start-ups. This report also comprises authenticate estimations to grow universally by contending among themselves and giving better and agreeable administrations to the clients.

With the slowdown in world economic growth, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size to maintain the average annual growth rate of 0.119642753799 from 2911.0 million $ in 2014 to 5122.0 million $ in 2019, Our analysts believe that in the next few years, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size will be further expanded, we expect that by 2024, The market size of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) will reach 14320.0 million $.

Have some queries? Get Free Sample PDF Copy of Latest Research on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: https://www.acquiremarketresearch.com/sample-request/214969/

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report includes PESTLE analysis, competitive landscape, and Porters five force model. Market attractive analysis wherein all the segments are benchmarked based on the market size, growth rate, and general attractiveness.

The report underscores the segmentation analysis of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market which is based on vital market segments such as types, regions, applications, technologies, and end-users. The proposed segmentation analysis helps clients in precisely targeting the actual market size and selecting the most lucrative segments for their Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) businesses. Eventually, the report drives clients to make informed market decisions and build effective business stratagems.

Grab Your Report at an Impressive Discount! With Corporate Email ID @ https://www.acquiremarketresearch.com/discount-request/214969/

Some of the key players operating in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market are: Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Creatv MicroTech, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, Aviva Biosciences Corporation, ScreenCell, Silicon Biosystems

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth by Types: CellSearch, Oncoquick, ISET, MACS

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Extension by Applications: Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment

The Global version of this report with a geographical classification would cover regions: North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Have Any Query? Ask Our Expert @(Use Corporate email ID to Get Higher Priority) @ https://www.acquiremarketresearch.com/enquire-before/214969/

Other important pointers included in the report: The study presents major market drivers that will augment the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market commercialization landscape. The study delivers a detailed analysis of these propellers that will impact the profit matrix of this industry positively. The study presents information about the pivotal challenges restraining market expansion.

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. If you have any special requirements, please let us know and we will offer you the report as you want.

Read more from the original source:
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 to 2024 Structure with Top down & Bottom up Approach, Technological Trends...

Read More...

Social interaction and purpose are essential to longevity – Aspen Times

November 4th, 2019 11:41 am

Editors Note: Sponsored content brought to you by Aspen Valley Hospital

Theres often a myth that assisted living somehow equates to a loss of independence, but residents often find more time to add healthy, meaningful activities into their daily lives when household chores are eliminated.

In Aspen, senior living at Whitcomb Terrace focuses on enhancing residents quality of life by providing an environment that is stimulating, nurturing, active and fun.

More and more evidence-based research suggests there are a number of benefits to senior-living residences versus remaining at home, said Dr. Joshua Seymour, medical director at Whitcomb Terrace in Aspen. The programming at Whitcomb Terrace provides the optimal structure from routine meals, regular exercise and memory stimulating activities, that lifts mood, lowers anxiety and improves memory.

The not-for-profit community, owned by Aspen Valley Hospital, has just 15 total residences, providing a family-like atmosphere that feels warm and welcoming for residents yet offers privacy and autonomy for those who want it.

Whitcombs current openings present a singular opportunity for Aspen Valley locals to claim a rare spot at Aspens premiere place to age well, said Whitcombs Director Maggie Gerardi, who has worked at the community for more than 18 years.

Timing is everything

Seniors and their loved ones often wait until daily chores and tasks become impossible before making the decision to move to an assisted living environment, but the time when seniors and their loved ones should start considering a senior living community is long before they think they need it.

So often people move in, and love it so much that they wish they had made the transition years before, Gerardi said. People dont realize the negative impact loneliness and isolation have on ones quality of life.

Meredith Daniel, activities coordinator at Whitcomb Terrace and a former, long-time performer at The Crystal Palace, said determining when this transition is an appropriate choice for a family member or loved one, or even for yourself, is understandably hard.

However, weve observed there are benefits derived from giving the responsibilities of daily life over to a qualified and loving team, Daniel said. Quality of life is naturally enhanced by social interaction, activity stimulation, and the relaxation that comes with having your daily needs met.

Your life, only better

The brain is just like a muscle that needs exercise when its not utilized, signs of depression and dementia can worsen, Dr. Seymour said. The National Institute on Aging reports that social isolation and loneliness are linked to higher risks of physical and mental conditions such as high blood pressure, heart disease, obesity, a weakened immune system, anxiety, depression, cognitive decline, Alzheimers disease, and even death.

Living in a communal environment with others it just makes people happier, he said, referencing both medical research and personal observations as medical director at Whitcomb Terrace. Many mild types of depression and dementia can be lifted.

While this type of living environment has been shown to lead to longevity, its never forced upon residents at Whitcomb Terrace. Not all residents want to participate in all of the activities or programs and thats OK residents can maintain their personal freedom and privacy while also taking advantage of the services and amenities provided, Gerardi said.

Grateful relatives

In 1960, mom came to ski bum in Aspen and worked for Drs. Whitcomb, Oden and Gould, said daughter Lisa Prior, who returned home to Aspen when it was time for her mother, Sharon, to relinquish some of the burdens of living independently. Dr. Whit was our family doctor so its really wonderful to feel his care living on in this way. Because Whitcomb Terrace is a small community, mom knitted right in with the other residents. The quality of care is so personal, everyone there has different aging issues, and the incredible staff are very responsive. Theres really nothing like it. Having mom at Whitcomb has erased the eldercare anxiety my sister, Bailey, and I have been living with for a few years now. And the icing on the cake is that our time with mom is not taken up with chores we hang out or head out to experience all the things we love about the Roaring Fork Valley.

An engaged community

Positive energy permeates through the community, where residents encourage each other to attend art shows, go for walks outside, head to the theater or to any other activity that piques their interests.

Residents get together daily to enjoy their shared interests, whether its through art, puzzles, bridge, Scrabble, movies, walking, music theyre often creating their own experiences together, Gerardi said.

With just 15 residents at maximum capacity, it really does create a family atmosphere staff included. Residents have their private apartments, and they also have the ability to go out as often as they like, participating in the same activities they did before moving in.

We provide a variety of opportunities for enrichment to encourage residents to remain active, Gerardi said. We have amazing meals and staff who cares for residents like family. We also acknowledge some residents choose to keep the same routines and independence they had prior to moving in. We treat each resident as an individual.

The best care and the best value in the valley

Whitcomb Terraces 15 senior living apartments have been recently renovated, and the cost is more affordable than people might expect. There are four apartment styles, ranging from small studios to large one-bedroom units, ranging from $3,500 to $6,000 per month. The price is all-inclusive of services, meals, salon services and more.

Whitcomb Terrace has several rare openings right now. For more information about the communitys services and amenities, visit aspenvalleyhospital.org/Whitcomb-Terrace-Assisted-Living.

To learn more about becoming a resident, contact Maggie Gerardi at 970-544-1530, or mgerardi@aspenhospital.org.

See the article here:
Social interaction and purpose are essential to longevity - Aspen Times

Read More...

If you haven’t turned 70 yet, don’t retire – Palo Alto Online

November 4th, 2019 11:41 am

Want to retire more comfortably? Work longer.

A Stanford University study on the financial benefits of delaying retirement until age 70 found that seniors can gain a significant amount of Social Security income to help offset drawing down their retirement savings.

The May 2019 joint report by the Stanford Center on Longevity and the Society of Actuaries studied how middle-income retirees can best maximize their financial power so they'll have enough to live on as they age.

"Viability of the Spend Safely in Retirement Strategy" found that working even a few extra years can mean a significant increase in retirement income. Most of the increased income comes from delaying Social Security benefits and not drawing down savings from your retirement account.

The "spend safely in retirement strategy" starts with the assumption that most older workers will fall short of commonly recommended retirement income goals -- unless they can continue to work into their late 60s or 70s.

But there are ways to manage even retirement income.

The spend-safely strategy anticipates that middle-income retirees will rely heavily on Social Security benefits. A previous 2017 study by the researchers found that among middle-income retirees who use the spend-safely strategy to build a retirement income, Social Security benefits represent between two-thirds to more than 80% of the portfolio. The dominance of Social Security benefits in the portfolio dampens the volatility in total retirement income from more aggressive investments, such as having a large proportion of stocks. Social Security benefits protect against the risks of longevity, inflation and market changes. The main drawback is if political winds shift and reduce Social Security payouts, the authors wrote.

The study examined 292 different retirement-income strategies. They also looked at five hypothetical models: people who retired completely at age 62 and started Social Security benefits; those who kept working part or full time until full-retirement age 66 1/2; and those who worked part or full time until age 70 before taking the benefits and drawing from their savings.

In one scenario, a 62-year-old, middle-income couple retiring in 2019 has a combined $100,000 household income and $350,000 in retirement savings. Their retirement income would be $70,755 if they worked full time until age 70. If they worked full time until age 66 1/2, their retirement income would drop to $53,031 annually. Retiring at age 62, they would have to live on just $37,585. The amounts are not adjusted for inflation.

Starting with more money doesn't necessarily mean retirees will be better off as they age, the researchers found.

An affluent couple with a $200,000 combined pre-retirement income and $1 million in retirement savings by age 60 would have a retirement income of $69,481 at age 62 and $128,156 if they worked full time until age 70.

Although a seemingly better financial outcome, the affluent couple would also fall short of their common retirement income goals. They would be taking proportionately more income from their savings compared to the middle-income couple. As a result, they have more income subject to the savings-eroding factors, such as longevity, investment and inflation risks, the report found. The researchers suggest the more affluent couple could benefit from refining their strategy or finding alternatives to the spend-safely model.

Since many retirees have inadequate savings, the analysis looked at strategies for boosting retirement income. A large portion of retirement income would come from Social Security, so retirees might put much of their savings in investments such as stocks -- the theory being they have little to lose and potentially much to gain with significant investments.

"If they invest mostly in fixed-income investments, they lock in their modest savings," the researchers said.

They compared retirement incomes based on ages 77 to 80 to see how nominal retirement income amounts might fare under various kinds of investments: annual income with 100% in stocks; annual income with 50/50 stock and bond allocations; and annual income with 100% invested in bonds. Over a 30-year retirement period, despite volatility, the 100% stock investment portfolio out-earned the 100% bonds or even the 50/50 stock-and-bond investments most of the time, but not always, the researchers found.

They acknowledged most retirees would not feel comfortable with a 100% investment in stocks -- even though the allocation of stocks to the total retirement income portfolio would be less than 50% when the value of Social Security benefits are included. Retirees could still benefit favorably with a 75% stock allocation, they said.

There are some savings built into retirement. Workers need a total retirement income that replaces 70% to 80% of their gross pre-retirement income to maintain their standard of living before they retired, the researchers pointed out. They won't need a 100% income replacement because retirees don't pay Federal Insurance Contributions Act payments and Medicare taxes, which account about 7.65% of pay up to the Social Security Wage Base ($132,900 in 2019). Medicare taxes kick in at 1.45% if the income is above the Social Security Wage Base, and are more for higher incomes. Retirees also pay significantly less for state and federal taxes, since a large portion of Social Security income is exempt from income taxes and taxpayers ages 65 and older have larger tax deductions.

---

Follow the Palo Alto Weekly/Palo Alto Online on Twitter @PaloAltoWeekly and Facebook for breaking news, local events, photos, videos and more.

Here is the original post:
If you haven't turned 70 yet, don't retire - Palo Alto Online

Read More...

Hawaii Natural Medicine Offers IV Nutritional Therapy for Wellness – KHON2

November 3rd, 2019 12:49 am

Posted: Nov 1, 2019 / 02:59 PM HST / Updated: Nov 1, 2019 / 02:59 PM HST

Honolulu (KHON2) IV Nutritional therapy is nolonger just a secret of the stars, its catching on with locals who see thebenefits of getting a cocktail of vitamins and minerals at HawaiiNatural Medicine.

Dr. Stephen Benchouk welcomed Living808 to seehow it works, saying IV Vitamin Therapy is anintravenous injection that delivers vitamins, minerals, and amino acidsnutrients directly to the cells of the body. These nutrients are directlyabsorbed into the circulatory system, bypassing the gastrointestinal tractthereby increasing the absorptive and therapeutic capability. It is oftenprescribed as part of a complete, holistic and individualized treatmentplan.

Many clients use IV therapyfor colds, flu, fatigue, jetlag, hangover, and dehydration, or for pre and postexercise recovery.

Clients fill out an intake form and based on the clients chief concerns, and an infusion is customized for that individual.

According to Dr. Benchouk, Morecomplicated cases such as cancer, autoimmune conditions and chronic diseasewill need a more comprehensive protocol which may include diet, supplements,herbs, medication, and life style changes.

IV Nutritional therapy has been around for years, Dr. Myers made it popular back in the 60s treating a variety of condition with a cocktail of vitamins and minerals.Since then, adds Benchouk, there has been decades of research on the effectiveness of using specific nutrients to treat specific conditions safely and without many of the side effects associated with some conventional medications. It has been used extensively by naturopathic doctors who are trained in application of therapeutic nutrition in both acute and chronic conditions.

Dr. Benchouk is a naturopathic doctor ora primary care physician who specializes in alternative and integrativemedicine. One of his most effective and popular treatments is IV vitamintherapy.

Clients are looking to treat the cause of their health concerns or looking for an alternative to convention medical treatments as those treatments come with side effects or are no longer effective. HNM specializes in integrative oncology, chronic conditions like autoimmune disorders, gastro intestinal disorders, endocrine disorders, most chronic conditions, and general wellness and prevention.

The IV treatments have gotten sopopular, HNM recently launched a mobile service called IV Drip Hawaii.

Mention Living808 and throughoutNovember, youll receive 15% off your introductory IV Vitamin Therapy.

Websites: http://www.hawaiinaturalmedicine.com https://ivdriphawaii.com/

Hawaii Natural Medicine islocated at 1188 Bishop Street, Suite 1605

View original post here:
Hawaii Natural Medicine Offers IV Nutritional Therapy for Wellness - KHON2

Read More...

Ticked off: Congressman Chris Smith Perseveres in the fight against Lyme disease – TAPinto.net

November 3rd, 2019 12:49 am

New National Lyme ResearchInitiative has roots in New Jersey

MONMOUTH COUNTY, NJ: At a press conferenceheld last Friday, October 25th,in the courtyard of the Wall TownshipMunicipal Building,U.S. Rep. Chris Smith (R-NJ), formally acknowledged and praised the recent launching earlier in the month, of theNational Institutes of Healths (NIH)national research strategy to combat Lyme disease.

Smith also expressed his frustration for the amount of years that it took to get to this point.

Sign Up for Holmdel & Colts Neck Newsletter

Our newsletter delivers the local news that you can trust.

You have successfully signed up for the TAPinto Holmdel & Colts Neck Newsletter.

Smith was joined at the presseventwith patients who suffer from Lyme disease, and also in attendance were Lyme research and treatment advocacy leaders.

U.S. Rep. Chris Smith (R-NJ), the co-chair of the congressional Lyme Disease Caucus,has been working on advancing research, treatment and funding for Lyme's Disease since1992,when Smith first met with top medical and health officials to discuss the topic in Washington.

Thenin1998, Congressman Smith co-sponsored the Lyme Disease Initiative Act of 1998, toestablish a program to provide for a reduction in the incidence and prevalence of Lyme disease. Smith has been a tenacious early leader in the fight against Lyme disease, a leader in theeffortto combat Lyme disease for over 27 years.

Congressman Smith commented, Everything that was imbedded in our first bill in 1998and every bill thereafteris captured in the five pillars in the NIH plan.We have waited for this initiative for a long time, but in launching this effort,NIH appears to be forging ahead for researching Lyme and other tick-borne diseases to better diagnose and treat those suffering from this horrific disease,"said Smith.

Smith mentioned that the new NIH planreads like the content of several of the bills he has introduced over the years pushing the federal government to establish a responsive, comprehensive, scientific strategy to help those gravely ill from Lyme and other tick-borne diseases.

Dr. Jodie Dashore, Ph.D., of Marlboro, an expert in integrative medicine specializing in neurology, who cares for Lyme patients from 40 countries,wasalso present and spoke at the event. Dashore'sson Brian was present in the audience to sharehis story. His isone riddled with multiple misdiagnosis, and a cripplingnear-deathjourneywith chronic Lyme disease. WatchTAPinto'sone-on-one breakoutinterview with Dr. Dashore:

VIDEO-Hear Dr. Dashore's powerful testimony:

Dr. Dashore also spoke about the link established between Lyme disease and autism. Her plant based treatmentshave successfully treatedpatients withLyme disease and also many with an autism diagnosis. New Jersey has a large population of people diagnosed with Lyme diseaseand heres the keyNew Jersey has a large population of people diagnosed with autism spectrum disorder, she said, estimating that 65 percent of her child patients with autism have Lyme.

She said more research into Lyme was needed, and was supportive of the NIH to kick off its national research plan."Clinical research is urgently needed for accurate testing of the multiple genospecies and multiple strains of organisms, along with human genetic and immunologic risk factors associated with tick borne illness, Dashore said. Early diagnosis, reliable testing and effective treatment strategies help contain the immunosuppressive complex biological expression of the disease thus preventing a prolonged and debilitating illness with a large socio-economic impact."

Priorities in the NIH multipart plan include the five pillars of: Expanding knowledge of tickborne diseases; developing rapid diagnostic testing; identifying treatment success and human biomarkers of persistent symptoms; developing new treatments; and evaluating prevention approaches such as vaccines.

Smith, the co-chair of the congressional Lyme Disease Caucus, is also the author of the pendingTICK Act(HR 3073), which will develop a whole-of-government National Strategy to prevent and treat Lyme and other vector-borne diseases.Smiths legislation would create a new Office of Oversight and Coordination for Vector-borne Disease in the Department of Health and Human Services coordinating strategies across the entire federal governmentincluding the NIH, and also the Departments of Defense, Agriculture, Interior, Homeland Security and the Environmental Protection Agency.

We have a bill calledThe Tick Actwhich would codify the idea of a national strategy, Smith said. He noted that the fight against Lyme disease is surging administratively, and thanked the Administration for directing federal agencies to see how Lyme disease can be addressed within their own departments.

In releasing itsStrategic Plan for Tickborne Disease Research, the NIH said the effort was inspired in part by the2018 Report to Congressby theHHS Tickborne Diseases Working Group(TBD Working Group). Smith spearheaded the legislation that created the TBD Working Group, which became a provision (Section 2062) ofthe21st Century Cures Act.

The Tickborne Disease Working Group met for months and came up with a report that demolished the myths about Lyme disease, like that chronic Lyme disease doesnt exist. The report recognizes that current diagnostics are totally inadequate. In terms of diseases and disabilities, it shows there is no other disease or disability that is as underfunded than Lyme disease. The Working Group Report has become the marching orders in the fight against Lyme disease,Congressman Smith said.

Also, at the press conference to speak wasPatricia Smith, president of the national Lyme Disease Association, and parent of a child who contracted Lyme disease. I have worked with Congressman Smith for 27 years to get the attention needed for Lyme, Ms. Smith said. Working on our 2018 TBD Working Group Report, we discovered NIH had no national strategy on Lyme and tick borne diseases. The Report to Congress recommended that one be developed. Two weeks ago, NIH released a comprehensive TBD research strategy which outlines what kinds of research needs to be done to help patients and to stop the spread of the disease.

VIDEO-Listen to Patricia Smith, president of the national Lyme Disease Association:

She called the NIH actiona good first step, and added we also need passage of the TICK Act to bring all tickborne disease under one office of government and to generate necessary funds for a comprehensive research plan.

Also speaking at the event were Lyme patients Debbie Scatuccio of Jackson, a mother of two children with Lyme and grandmother of two with Lyme.Brian Dashore is asenior at Monmouth County Academy of Health Science. Hehopes to become an immunologist, in part because of his own battle with Lyme disease. I am motivated by my own experience with the disease and because the health care field is so interesting, Brian said. Ive mentored kids with Lyme, he said, discussing such issues as bullying, extended days out of school, and his own experiences including pain, brain fog and fatigue.

Scatuccio said the NIH research plan was a long time in coming, and was happy the TICK Act was sponsored by her own member of Congress from New Jersey, Rep. Smith (R-NJ), with the lead cosponsor a member from her former state of residence Minnesota, Rep. Colin Peterson (D-MN). Smith and Peterson co-chair the Lyme Disease Caucus on Capitol Hill.

It was very important it was bipartisan, Scatuccio said. I am proud that the two Members of Congress from the two states which are dearest to my heart, are helping our country. The people of the United States deserve to get the right care.

Dr. Robert C. Bransfield, M.D, Clinical Associate Professor at Robert Wood Johnson UMDNJ Medical School, President of the International Lyme and Associated Diseases Educational Foundation who has worked with Smith on Lyme issues in the past, said that the main cause of death from Lyme disease is suicide and a major cause of disability from Lyme disease are mental and cognitive impairments.

Many who see themselves as authorities on Lyme disease have little training in psychiatry and are unable to comprehend how a tick bite can result in mental illnesses, Bransfield said.

Originally posted here:
Ticked off: Congressman Chris Smith Perseveres in the fight against Lyme disease - TAPinto.net

Read More...

Two minutes to lift your mood – Times of India

November 3rd, 2019 12:49 am

You dont need big changes to lift your mood. Turn around your hectic day in a jiffy with a few quick tricks Flip through photosWhen you are feeling down, pick your childhood albums or take out your kids baby albums. It may actually make you feel happier than a square of chocolate. Researchers at UKs Open University found this after they examined how much peoples moods rose after looking at personal photos. The study says viewing your old or new happy pictures makes people feel 11% better. Inhale calming scentsFill your indoor space with vanilla or lavender essence. In an Austrian study, researchers wafted the smell of lavender for people. The group felt less anxious, more positive, and calmer when compared with participants not exposed to any fragrance.Open the windowsTo feel happy in seconds, let sunlight stream in. One study of more than 450 women found that those who got the most light, particularly in the morning, reported better mood. Combine exercise with morning light. The exposure amplifies lights beneficial effects on mood, sleep, and alertness.Watch a funny videoA hearty laugh produces a chemical reaction that instantly elevates your mood. When stress builds up or you feel you may snap, make yourself giggle: Watch a funny video clip online.Chop vegetablesYes, this is therapy. According to Andrew Weil, MD, an integrative medicine expert, after a particularly emotional and stressful day, the act of chopping vegetables creates something wonderful this process neutralises the negative mental state in no time.Massage your handsThe act of massaging your hands with oil or cream and rubbing them instantly lifts your mood. Hands and wrists have your pulse points. Happiness is just a tight squeeze away. According to Matt Hertenstein, associate professor of psychology, DePauw University (Indiana, US), even 10 minutes with a massage therapist (or a generous friend) will light up your brains reward centre, get the oxytocin flowing, and have a big effect on your mood, not to mention help relieve aches and pains. Most scientists think that even self-massage, like rubbing your own feet, can rid you of negative emotions.

Visit link:
Two minutes to lift your mood - Times of India

Read More...

Get disciplined post festivities – Times of India

November 3rd, 2019 12:49 am

Festivities are a time of joy, celebration and of course food! For many people, the idea of indulging in festive food overwhelms them and the fear and stress of piling on weight creeps up. Well, firstly, its necessary to understand the connection between food and the kind of relationship you build with it. Food is not the reason why you gain weight or suffer from a health condition. The culprit is the person eating it and his/her lifestyle. Its a bitter truth that most of us dont want to hear. So, while you consciously practice mindful eating, portion control, moderation, proper chewing, here are some more lifestyle tweakings you can adopt to maintain good health. Mind you, these are simple, inexpensive and natural ways. All you need is self-discipline and effort. Tabata before treat! Tabata workout is a great way to stoke your metabolism in less than 4 minutes. Its a set of 8 exercises that makes you work out at a maximum intensity for 20 secs followed by 10 secs. Exercises like planks, squats, lunges, push-ups, jumping jacks, high knees can easily fit into a Tabata. Four-minute Tabata is powerful because it turns body into a fat-burning machine and keeps metabolism high for the next few hours.

Sure, you always listen to your body when it comes to adopting a new exercise, else you risk injury. Jerky movements may not suit those who suffer from knee issues, so you may want to carve out a Tabata plan that suits your health condition. There are various Tabata apps and YouTube videos that can help you find the best fit. Time your dessert Dont gorge on the leftover sweets. Its an in-built intelligence of our body that directs us to eat, digest, absorb, assimilate, sleep, secrete certain hormones at a specific time of the day. We function best when we live as close to our circadian rhythm as possible. Our circadian rhythm has a huge effect on various metabolic processes in our body. It turns out, that our metabolism is at its peak during the afternoon, meaning that it is the best time of the day to fit in a dessert or any treat meal. As the day proceeds, our metabolism dips and slows down. Also, we do not need additional energy (read carbohydrates) at night because its requirement is much less when we sleep and rest.

That said, these strategies are not a free ticket to go all out and overdo on sweets. We still need to practice moderation, portion control, healthy relationships with food and above all, guilt-free eating.

Follow this link:
Get disciplined post festivities - Times of India

Read More...

Lecture: The Natural Path to Boosting Immunity and Mood – mySanAntonio.com

November 3rd, 2019 12:49 am

Published 9:00am CDT, Friday, November 1, 2019

Photo: Contributed Photo.

Lecture: The Natural Path to Boosting Immunity and Mood

Winter is fast approaching and while many enjoy the New England change of seasons, the winter months also bring the challenge of preserving good health and mood. New Canaan Library welcomes nutritionist/dietician Jay Wolkoff, who will discuss how integrative and natural strategies can boost immunities and ones overall sense of well-being on Sunday, Nov. 10, at 2 p.m. in the Adrian Lamb Room. To register, visit newcanaanlibrary.org.

While modern-day living allows us to largely insulate ourselves from the outdoors and enjoy produce from temperate and tropical climates, there also is a certain beauty to acclimating our bodies to the cooler months with warming foods, herbs, and spices. In his presentation, Jay Wolkoff uses his extensive knowledge of nutrition and the sciences combined with integrative strategies to demonstrate how one can support their bodys natural immunity as well as keep their mood up during the darker and cooler months.

Wolkoff, nutritionist/dietician, MS, CNS, CDN, is passionate about providing individualized and comprehensive dietary and lifestyle support to his clients. His unique approach towards health effortlessly weaves together his background in evidence-based nutrition and the emerging sciences, clinical herbalism, appreciation for mind-body medicine, passion for organic gardening, and love of the outdoors.

Here is the original post:
Lecture: The Natural Path to Boosting Immunity and Mood - mySanAntonio.com

Read More...

Pollution In Delhi: Herbal Teas And Other Ways To Reduce Cough, Cold And Other Health Risks – NDTV News

November 3rd, 2019 12:49 am

Delhi Pollution: Keep your indoors clean and dust-free to prevent air pollution health risks

Air quality in Delhi has reached severe category and people have started to experience the health hazards associated with it. Many are experiencing increased coughing, sneezing, irritation in the throat, etc. Alongside is the dip in weather, which is only making things worse. This is the perfect time to have some soothing, herbal teas that can provide relief from health hazards associated with air pollution and also calm you down. In an effort to help with respiratory problems deal with the hazards effects of air pollution, lifestyle coach Luke Coutinho takes to Instagram to share a herbal tea.

Made with ginger, cinnamon and other herbal spices, this herbal tea can reduce irritation in throat, cough, cold, sneezing, etc. You can have it early in the morning, in between meals or in evening.

Sipping warm tea during change in weather in rising pollution can have a soothing effect on your throatPhoto Credit: iStock

Also read:Prolonged Air Pollution Could Affect Your Mood And Work Productivity

To prepare this herbal tea, you need ginger (1 inch piece). 1 tsp of dried ginger powder can also be used as a replacement. Then, take Ceylon cinnamon stick (1) or cinnamon powder (1/4 tsp); basil/tulsi leaves (1/2 tsp); dry or fresh oregano (1 tsp); pepper corns (3), crushed elaichi (2); fennel seeds (1/4 tsp); ajwain or carrom seeds (a tiny pinch); jeera or cumin (1/4 tsp). You can also add optional ingredients: 1-2 cloves of crushed garlic.

Take all the ingredients and them in 2 cups of water. Boil them and reduce it to half. Strain the ingredients and sip on it warm. You can also add some honey or jaggery to the herbal to sweeten its taste.

Also read:Here's How You Can Protect Yourself From Poor Air Quality

1. An age-old and effective home remedy to control cough is chewing some jaggery or gud. Not only does it help in controlling cough, it can also help in removing harmful toxins from your lungs and respiratory tract.

2. Include more ginger in your diet. Apart from the herbal tea mentioned above, you can also try ginger, honey and lemon tea. You can take some grated ginger, lemon juice and honey and add it to boiling water. Strain the mixture and sip warm. It can control your cough, cold and congestion. Ginger contains gingerol and other compounds that can reduce inflammation in the airways and inhibit airway contraction.

Anti-inflammatory properties of ginger can reduce air pollution health risksPhoto Credit: iStock

3. You can also include garlic in your diet as it boost your immunity and help in fighting infections. Garlic has anti-inflammatory properties that can reduce symptoms of asthma as well.

Also read:Beat Ill Effects Of Air Pollution With These Lifestyle Changes That Can Cleanse Your Lungs Naturally

4. Citrus fruits like lemon, amla and oranges can boost your immunity and reduce respiratory symptoms caused by air pollution. Vitamin C in citrus fruits have beneficial effect on the body's immunity.

5. Basil (tulsi) juice or tulsi tea is another herbal tea you can have this time of the year. It can keep you warm and reduce ill effects of air pollution.

6. There is nothing that a soothing cup of turmeric latte won't do during cough and cold. From boosting your immunity to reducing inflammation, the traditional haldi doodh is the perfect remedy for dealing with congestion, sneezing, wheezing, cough, cold and asthma.

(Luke Coutinho, Holistic Lifestyle Coach - Integrative Medicine)

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.

Read the rest here:
Pollution In Delhi: Herbal Teas And Other Ways To Reduce Cough, Cold And Other Health Risks - NDTV News

Read More...

Turmeric: what are the benefits and is it good for you? – The Irish Times

November 3rd, 2019 12:49 am

Have you noticed lattes, ice cream and smoothies with a tawny hue? That could be a sign of a not-so-secret ingredient: turmeric. The botanical is omnipresent in health food aisles, in the form of pills and powders.

Turmeric, native to South Asia, is one of the fastest-growing dietary supplements. In 2018, products racked up an estimated 300 million in sales in the United States, a more than sevenfold increase from a decade earlier, according to a report from Nutrition Business Journal.

Brightening up the pantries of many homes in India, the spice is interwoven into daily life, the cuisine, and cultural and healing traditions. A member of the ginger family, it has been used in ayurvedic medicine for thousands of years. Apply turmeric to wounds, and its believed to fight infection. Mix it with milk, and the mind calms. Tint the entrance of new homes with a paste to welcome prosperity.

Turmeric is auspicious and one of the most important herbs, said Anupama Kizhakkeveettil, a board member of the National Ayurvedic Medical Association.

Sliced open, or dried into a spice, the Curcuma longa plant imparts its amber colour and earthy, bitter flavour to food like curry. The active ingredient captured in many turmeric supplements is curcumin. Curcumin, along with the other curcuminoid compounds, compose only about 3 per cent of the dried spice.

And bottles will often say turmeric on the front but list curcumin in the ingredients.

Turmeric is hailed for helping a host of conditions: high cholesterol, hay fever, depression, gingivitis, premenstrual syndrome and even hangovers. In ayurvedic medicine, it is believed to act as an anti-viral, anti-bacterial and anti-parasitic, and has long been used to help with diabetes, pain, rheumatism, osteoarthritis, memory and skin conditions like eczema.

We use it for so many different conditions, its a time-tested herb, Kizhakkeveettil said. Unfortunately, our science doesnt fit into complete randomised controlled trials. That is alternative medicines biggest challenge.

Researchers sought to answer this by sifting through the available literature. In a 2017 paper in the Journal of Medicinal Chemistry, they concluded its fools gold. There are claims that it can cure everything, said Kathryn Nelson, a research assistant professor at the University of Minnesota and the studys lead author. To me, that is a red flag.

Dr Amit Garg, a professor of medicine at Western University in London, Ontario, knew about turmerics medicinal use because of his Indian heritage. He knew first hand of its rich cultural significance too: on his wedding day, his relatives rubbed the spice all over him because it is believed to be cleansing.

After seeing the effectiveness of curcumin, in smaller studies, Garg and his colleagues decided to test it on a larger scale in hopes it would make elective aortic surgery safer by reducing the risk of complications, which include heart attacks, kidney injury and death. In the randomised clinical trial that followed, about half of the 606 patients were administered 2,000 milligrams of curcumin eight times over for four days, while the others were given a placebo. It was a bit disappointing, but we couldnt demonstrate any benefit used in this setting, Garg said of the study, published last year in the Canadian Medical Association Journal.

In fact, there is not enough reliable evidence in humans to recommend turmeric or curcumin for any condition, according to the US National Center for Complementary and Integrative Health. Turmeric became a nutritional golden child partly because of its promise in laboratory studies cellular and animal. Some research indicates that both turmeric and curcumin, the active ingredient in turmeric supplements, have anti-inflammatory, antioxidant, anti-bacterial, anti-viral and anti-parasitic activity. But this has mostly been demonstrated in laboratory studies, and, in many cases, the benefits of preclinical research isnt observed in clinical trials.

According to Natural Medicines, a database that provides monographs for dietary supplements, herbal medicines, and complementary and integrative therapies, while some clinical evidence shows that curcumin might be beneficial for depression, hay fever, hyperlipidemia, ulcerative colitis, osteoarthritis and nonalcoholic fatty liver disease, its still too early to recommend the compound for any of these conditions.

And Natural Medicines has found there isnt enough good scientific evidence to rate turmeric or curcumins use for memory, diabetes, fatigue, rheumatoid arthritis, gingivitis, joint pain, PMS, eczema or hangovers.

Physicians say more research is needed. Dr Gary Small, a professor of psychiatry and biobehavioral sciences at the David Geffen School of Medicine at the University of California, Los Angeles, who studies curcumins effect on memory, sees a lot of therapeutic potential. He also states that existing research demonstrates curcumins biological effects.

What may be affecting curcumins efficacy, doctors say, is that it is poorly absorbed from the gastrointestinal tract. In Indian cooking, turmeric is usually heated in a fat, like oil, which can increase absorption. Certain supplement manufacturers are also taking steps to improve this curcumins bioavailability by combining the compound with other components. For instance, a chemical found in black pepper called piperine is sometimes added to curcumin supplements in proprietary blends to increase its absorption.

Researching curcumin can be challenging because some blends have better bioavailability than others, and varying amounts of the active ingredient. If you did the study over and over again but used slightly different preparations, you would probably have different results, said Dr Janet Funk, a professor of medicine at the University of Arizona College of Medicine, who studies curcumins effect on bone.

Still, even if absorption improved, curcumin would not have any biological effects, Nelson contends. Turmeric may still have health benefits, she said, but they just may be from another compound or combination of compounds.

Consuming it by mouth is safe, up to 2g of turmeric daily for a year, and 4g daily of curcumin for a month, according to Natural Medicines. Turmeric aficionados who also use it as a face mask can relax too; the database indicates it is most likely safe to apply to the skin.

Doctors recommend that patients tell a physician they are taking turmeric. High doses of turmeric and its isolated constituents can have some rather unpleasant side effects, including diarrhea and nausea. Curcumin may also interact with anti-coagulants and anti-platelets, antacids, and drugs used for chemotherapy and to control blood pressure. While the spice is considered safe in food, therapeutic doses should be avoided during pregnancy.

The US Food and Drug Administration does not test dietary supplements such as turmeric for safety and effectiveness but announced this year that it would improve oversight of the growing industry.

One study published in 2018 in Molecular Nutrition & Food Research, found that the cheaper the turmeric product, the more likely it was to have chemical compounds suggestive of synthetic curcumin; and products with turmeric root were more likely to have higher lead levels. One sample exceeded recommended limits for lead.

How about all those turmeric lattes? Doctorssay that sprinkling a little bit of the bitter spice into frothed milk doesnt have proven health benefits. But that doesnt mean it isnt delicious.

As for Garg, he is not closing the bottle cap on curcumin. To wit: he is in the middle of a randomised study with a different preparation and dosing to see if curcumin prevents the progression of kidney disease. There are still many promising things about curcumin and turmeric, he said. I remain open-minded. New York Times

Original post:
Turmeric: what are the benefits and is it good for you? - The Irish Times

Read More...

How The Blue Blood Of The Horseshoe Crab Is Helping Us Detect Bacteria Beyond Earth – Maritime Herald

November 3rd, 2019 12:49 am

This post has been brought you by laroja-deportesonline.com The best online site to Watch Live Soccer Matches

Blue blood of a crab-arachnid in space to detect possible infections of an astronaut in full galactic mission. If this has not caught your attention: Houston, we seem to have a serious problem. As crazy as this first idea may seem, we would not try to make curiosity knock on your door without a good argument. In fact, the statement you just read is true and the blood of the animal you are referring to, is much more important than it seems.

Despite its name, do not be fooled, it is neither a crab, nor has a horseshoe shape. In fact, at first glance it may seem more like a small species of stingray with a built-in shell or even one of those robot vacuum cleaners that leave your living room unpolluted. It could easily be part of the cast of Star Wars alien creatures. As you can imagine, its shape is far from what we would think when talking about a conventional crab.

Disturbing as well as disconcerting, this could be the presentation and a first contact with the Limulus polyphemus, known by his relatives, effectively, as a horseshoe crab. There are five species of these animals, the most common are distributed along the Atlantic coast of the United States and can be observed in the spawning periods, in the sand, on the shores of the sea, explains Xakata Begoa Snchez Chilln, conservative of arthropods of the National Museum of Natural Sciences. The rest of the species are distributed in East and Southeast Asia, where due to their great exploitation they are at high risk of extinction, he adds.

But then, is it a crab or not? As we anticipated, no. According to this study, published in 2019 in the scientific journal Systematic Biology , despite belonging to the group of arthropods, the horseshoe crab family is closer to arachnids than to crustaceans . To make it more visual: throw spiders more than crabs. Of course, unlike spiders, it has 6 pairs of appendages and an exoskeleton or shell that constitutes the union of the head and thorax, says Snchez.

Currently, the comparison of thousands of genes has revealed this new hypothesis , he told Xataka Jesus A. Ballesteros, researcher at the Department of Integrative Biology at the University of Wisconsin-Madison (USA) and one of the study authors. These results require scrutiny and corroboration, but they reveal a part of the complexity of the evolutionary process ; the same processes that have shaped and continue to shape the tree of life of which we are part, he adds.

But it is not the name or form of this curious animal that makes us write about it today, but its blood , both for its appearance and for its medical applications. According to Snchez, the primitive enzymes this animal attack the material of the cell walls of most bacteria , so they are frequently used in tests to detect bacterial endotoxins in numerous pharmaceutical products.

What is special about the horseshoe crabs blood?

As if it were a member of royalty, the blood of our protagonist is blue . While the human is red by a pigment of this color, hemoglobin, and its corresponding iron content; its analogue in this arthropod causes its hemolymph to acquire a different hue.

Hemocyanin (which contains copper instead of iron) is the one that gives blue color to the blood of the horseshoe crab, explains Xataka Susana Enriquez, a researcher at the Institute of Marine Sciences and Limnology (ICML) of the National Autonomous University of Mexico . But the value of this bugs blood resides in cells called amebocytes , which function as their immune system: when they come in contact with endotoxins produced by pathogenic bacteria, they solidify to alert that there is work to be done and start counteracting an infection .

These compounds [endotoxins] are very abundant in the membranes of gram-negative bacteria, which are the majority of those that live in the marine environment, says Xataka Gema Hernndez-Milia, a biologist specializing in marine mammal food ecology. They could be compared to the pieces of a puzzle: the enzymes in their blood cells coincide with the endotoxins and bind to them, creating a clot that prevents the consequences of the bacteria, he adds.

Since being studied, the blood of this crab has been a revolution in the world of medicine . In fact, if youve ever had a flu shot or know someone with a pacemaker, you owe the animal one.

According to the Horseshoes Crab website , developed by the Ecological Research and Development research group, a non-profit organization that has been fighting to conserve the four species of horseshoe crab since 1995, the quality of vaccines, injectable medications, intravenous solutions and medical implants are checked using the blood of this crab.

In addition, the Food and Drug Administration (FDA) has used it since 1970 (the year until rabbit blood was used in this task) to approve medications , making sure they are free of endotoxins. Why? We tell you his story.

Although shallow, the sandy seabed in which the arthropod inhabits, along the east coast of North America and Central America, are often plagued with bacteria . Their own habitat, therefore, poses a threat in itself: in other circumstances, these microorganisms could cause all kinds of infections. Here is the survival key of our protagonist of blue blood.

The primitive immune system of this distant relative of the trilobites is based on a blood coagulation mechanism that protects it from the endotoxins to which it is continuously exposed. The blood cells of the horseshoe crab, the amebocytes, contain proteins that are released in response to the presence of unwanted organisms, such as gram-negative bacteria. In this way, they get their blood to clot around the lesion and bacteria, protecting the animal, the authors explain on the web.

That is, the bacteria are trapped and unable to continue advancing through your body.

This defense mechanism, which was recorded for the first time as early as 1885 and which was studied in depth since the 1950s, is known as Limulus amebocyte lysate (LAL). Its effectiveness is such that it can detect the contamination with endotoxins of Gram-negative bacteria in incredibly low concentrations.

But what does blue blood have to do with space?

We return to the beginning, to our eccentric and first statement: Blue blood of crabs- arachnids in space to detect the possible diseases of an astronaut in full galactic mission. For now, we give the okey to the first concept, but what about the rest? What does this substance have to do with space, astronauts and disease detection?

NASA, through this article on its website, puts us in a situation: Imagine an astronaut on a space mission to Mars, halfway from Earth, which begins to feel bad. His throat hurts and he seems to have a fever, but he does not want to get sick or infect his companions. Should I take an antibiotic? And if so, what kind?

As a solution to this question, NASAs Marshall Space Flight Center developed the LOCAD-PTS (Lab-on-a-Chip Application Development-Portable Test System), a portable device that allows rapid detection of gram- negative pathogenic bacteria in space thanks to the LAL. How?

Thanks to this machine, a possible infection can be detected much faster than it would be to wait for the results of a culture in a Petri dish, explains Enriquez. According to NASA; lets you know if certain types of bacteria are present on the surfaces of space stations.

The reaction occurs with the endotoxins found in the membrane of these bacteria or some fungi (the same happens with the profenoloxidase of the Jonah crab) that allow to detect gram-positive bacteria, he explains to Xataka Hector Socas Navarro, a physicist at the Institute of Astrophysics of the Canary Islands and director of the Museum of Science and Cosmos of Tenerife. These enzymes go in different cartridges of the system, with which the collected sample is reacted, he says.

But its usefulness does not end here: the system not only locates a possible infection, but indicates what type of antibiotics would be necessary to combat such bacteria. It was an interesting development: gram-negative bacteria are among the most pathogenic, responsible for many respiratory, urinary and gastrointestinal diseases in humans, says Enriquez. In addition, he adds, it is the resistant ones that cause the most problems in hospitals.

This test is useful for the astronaut who feels that he is beginning to have health problems. Thanks to it, he can check the causes of the discomfort quickly and stop the infection (if any) at an early stage , long before the disease develops and he himself was a source of bacteria for his companions.

According to Enriquez, when the infection is still incipient, the culture in Petri dishes is not as effective or, at least, it requires more time for the crop to grow and confirm what type of bacteria is growing. As a result, the diagnosis comes later, making the infection more likely to be greater , not only within an astronaut, but within the ship for the entire crew. I think it is a potentially useful tool to quickly slow down the progress of possible infections by gram-negative bacteria, he concludes.

In the words of Socas, this system was also used between 2006 and 2009 to investigate the presence of bacteria and fungi in different places of the International Space Station (ISS). Afterwards, this technique stopped being used, giving way to more sophisticated methods (the PTS did not allow to identify which microorganisms had been detected, something that is possible today with molecular analysis technologies).

Currently, experiments are being carried out with polymerase chain reaction (PCR) that allow amplifying any piece of DNA that is present: make many copies of the fragment and facilitate its detection, Socas says. Several experiments between 2015 and 2016 have allowed us to know more about these bacteria and fungi. The dominant population of microorganisms is associated with the human microbiome , although there may also be opportunistic pathogens.

To avoid confusion, Socas insists that we talk about terrestrial microbes dragged by the missions themselves and the astronauts who have gone to the ISS. Their study is important in order to understand the possible extension of microorganisms carried by humans in future missions and to the health of astronauts, especially considering that there appear to be effects on the immune system of prolonged permanence in space.

In fact, the US National Research Council recommends in the ten-year review of its committee of biological and physical sciences of space that NASA establish a large-scale microbial observation program at the ISS.

Does the horseshoe crab survive after bleeding?

In order to obtain the liquid gold that supposes the blood of the horseshoe crab, the companies capture adult specimens of this species, extract a third of their total blood and release them again. However, these species of xiphosuros have to pay a very high price, since death during the process occurs in about 15% of individuals, says Snchez. Some reports also indicate that this mortality may be even higher due to bad practices during collection and transportation .

This, together with the influence that climate change is having on the seas, makes the four species that exist today are in a serious and growing danger of extinction, he adds.

According to the Ecological Research and Development Group, in 2016 the mortality associated with the production of LAL was around 70,600 animals per year , which shows that the species decreases worldwide given its great use for biomedical tests.

To avoid the possible disappearance of the horseshoe crab, which would be a great loss due to its ecological, agro-livestock and fishing interest , as well as biomedical, studies like this, published in 2018 in the scientific journal PLOS Biology , have investigated similar options, thanks to the that you could enjoy a synthetic alternative to this substance. Unlike LAL, the technique (recombinant Factor C, rFC) would use a cloned arthropod protein as an active ingredient.

The proven efficacy of this alternative to detect endotoxins is an opportunity for the pharmaceutical industry to modernize its procedures and contribute to the conservation of horseshoe crabs, the authors explain at the conclusion of the research: using the CFR would reduce the 90 % in the demand for LAL. That is, the mortality of the horseshoe crab would decrease , according to the research, by about 100,000 specimens annually in North America alone. It is a more humane and more ecologically sustainable method, they conclude.

Source: Xataka

Marketing manager and co-Chief Editor of Maritime Herald.

View post:
How The Blue Blood Of The Horseshoe Crab Is Helping Us Detect Bacteria Beyond Earth - Maritime Herald

Read More...

Willowbrook-based research facility receives $1.95 million grant to study rare diseases – SILive.com

November 3rd, 2019 12:48 am

The National Institute of Health (NIH) has awarded the Willowbrook-based Institute for Basic Research (IBR) a $1.95 million grant over five years to support the study of rare diseases linked to genetic abnormalities.

Although the state-operated facility has expanded its mission in recent years, scientific research into developmental disabilities has been at the core of IBRs work since its founding more than five decades ago.

In that tradition, the NIH award will fund research led by Dr. Gholson Lyon, an IBR psychiatrist and scientist who heads the Genomic Medicine Laboratory in the Department of Human Genetics.

The grantprovides science investigators who have demonstrated ability to make major contributions to medical science the freedom to embark on ambitious, creative, and/or longer-term research projects, the New York State Office for People With Developmental Disabilities (OPWDD) said in a press release.

According to OPWDD, the research will further understanding of the genetic basis for rare diseases that include Ogden syndrome, which was discovered and named by Dr. Lyon.

Occurring in an estimated one of 1,000,000 births, Ogden syndrome is characterized by craniofacial abnormalities, hypotonia, global developmental delays, cryptorchidism, cardiac anomalies, and cardiac arrhythmias, says OPWDD.

The disease is connected to mutation of the NAA10 gene, which affects the bodys proteins and the ability of cells to proliferate. In addition to Ogden Syndrome, Dr. Lyons clinical studies will also focus on other diseases tied to NAA10, and a related gene, NAA15.

These diseases have a profound impact on families, said Dr. Lyon. I am grateful for this support from OPWDD and [the National Institute of Healths National Institute of General Medical Sciences].

Dr. Lyon also works with families at IBRs George A. Jervis Clinic, which offers diagnostic and consultative services for children and adults with intellectual and developmental disabilities.

In addition to Ogden syndrome and related diseases, Dr. Lyon also researches Fragile X syndrome, autism syndromes, and investigates the physiological basis of neuropsychiatric conditions, with the goal of expanding access to preventive services and treatment for those disorders, according to his online bio.

IBR Acting Director Joseph J. Maturi said, Dr. Lyons extensive medical and scientific training and experience will help him successfully undertake these ambitious and important studies."

See the original post here:
Willowbrook-based research facility receives $1.95 million grant to study rare diseases - SILive.com

Read More...

Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology – Business Wire

November 3rd, 2019 12:48 am

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced that it has entered into a collaboration and license agreement with a newly-formed company, Prime Medicine, Inc. to research and develop a novel gene editing technology called prime editing, recently developed by one of Beams co-founders, David Liu, Ph.D., and his group at the Broad Institute of Harvard and MIT.

Under the agreement, Beam has the exclusive right to develop prime editing technology for the creation or correction of any single-base transition mutations, as well as for the treatment of sickle cell disease, both of which Beam is already pursuing with its base editing technology. Transition mutations (e.g. A to G, C to T) are the largest single class of disease-associated genetic mutations, and are also potentially treatable with base editing. Beam plans to evaluate prime editing technology for potential use in future programs.

Part of Beams strategy is to continue to access emerging technologies in gene editing and delivery, while finding new ways to create meaningful options for patients. Our collaboration with, and contribution to the formation of, Prime Medicine is a great example of that approach, allowing us to incorporate prime editing into the Beam platform, said John Evans, chief executive officer of Beam. This partnership enables both companies to advance the technology in distinct spaces, with Beam focusing on the kinds of edits that are most similar to our base editing technology.

As part of the collaboration, Beam is providing initial interim leadership to Prime Medicine for the first year of the collaboration, and will have the right to designate a member on Prime Medicines board. The parties will also grant each other non-exclusive licenses to certain CRISPR technology and delivery technology to enable the development of prime editing products.

About Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Beam is headquartered in Cambridge, Massachusetts. For additional information, visit http://www.BeamTx.com.

Read the rest here:
Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology - Business Wire

Read More...

Page 851«..1020..850851852853..860870..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick